Both in vitro and in vivo studies reported the effects of LSD1 inhibitors in terms of anti-leukemic activity, reduction of LSCs growth, induction of cell differentiation and increased survival in mouse models of AML (Chen et al., 2012). The gene discussed is KDM1A; the disease is acute myeloid leukemia.